Xoma (XOMA)

Biopharmaceuticals; Health Care

Develops biopharmaceuticals that target cancer, immunological disorders and infectious diseases. Its product, RAPTIVA, is the first FDA-approved biologic therapy designed to provide continuous control of chronic moderate-to-severe plaque psoriasis.

http://www.xoma.com/